|
THE
HISTORY OF THE DISCOVERY OF NATURAL PROGESTERONE
William Allen and George Corner first isolated
progesterone in 1934 and proposed the name
because of its progestational activity in
the pregnant female. At that stage he was
unaware of the many roles this hormone plays
in females as well as in males.
In the medical field, Progesterone was used,
primarily for women who continually had
miscarriages, with great success.
It had to be extracted from the placentas
of women who had just given birth and was
a very expensive product.
It was not until 1943 that Russell E. Marker
first synthesised the Natural Progesterone
molecule from the sapogenin and disogenin
extracted from plants. He should have
called this molecule the REAL
progesterone, as it is the identical molecule
produced in our bodies. Once it was found
that progesterone could be made in bulk,
biochemists began converting it into all
the other hormones we use today, including
: cortisone, testosterone, oestrogen and
the synthetic progestogens (which are also
known as progestins). With the birth of
all these syntheic drugs, natural or real
progesterone was forgotten.
SYNTHETIC DRUGS and the difference between
NATURAL PROGESTERONE and the drugs PROGESTINS
AND PROGESTAGENS
There is still much confusion in the minds
of both the laity and the professions between
progesterone on the one hand, and the progestogens
(or progestins) and yam creams on the other
.Progesterone is made in our body from cholesterol,
which is first broken down into pregnenolone
and then into progesterone, which in turn
can be broken down naturally into the other
hormones we need.
A limited number of preparations now use
the real progesterone molecule.
NATURONE cream is one that contain
"natural" progesterone. It is
described as "natural" because
it has an identical molecular structure
to the progesterone made by the body.
The progestins and progestogens on the other
hand have an altered molecular structure
which means that they can be patented. It
also means that they behave in the body
in radically different ways to progesterone
itself. The only similarity between them
and progesterone is their ability to maintain
the endometrium, the lining of the uterus,
thus making them effective contraceptives.
Unlike progesterone, which has no toxic
side effects, the progestogens are highly
toxic because of their altered molecular
structure. Some of the known side effects
are:- an increased risk of abortion and
congenital abnormalities if taken by pregnant
women; fluid retention; epilepsy; migraine;
asthma; cardiac and renal dysfunction; depression;
breast tenderness; nausea; insomnia; a drop
in the blood progesterone levels, and many
more. The long term effect of progestogens
on adrenal, herpatic, ovarian and uterine
function is unknown.
The pursuit of profit has far outweighed
the well-being of women and more drugs and
more profit are found in the side effects.
Beware of WILD YAM Creams. The yam creams
do not contain progesterone. They do contain
the plant steroid diosgenin, but the body
cannot convert diosgenin into progesterone.
The yam creams can have a beneficial adaptogenic
effect on the body, but unlike progesterone
they cannot effectively correct hormonal
imbalances such as excessive levels of oestrogen.
Progesterone cream is currently being used
by thousands of women in the western world.
The speed with which the cream relieves
symptoms varies. Some women find relief
within five days, in others it can take
three months, while the reversal of osteoporosis
can take six months or more. Many menstruating
women find that they can discontinue using
the cream after a few months as their symptoms
have cleared up, though continuation with
small doses is recommended because of its
anticancer properties.
SYMPTOMS of OESTROGEN
DOMINANCE
| |
Increase in allergies |
| |
Auto-immune disease |
| |
Mastitis, breast
tenderness and fibrocystic breasts |
| |
Breast cancer and
an increase in other oestrogen dominant
cancers such as cervical cancer, endometrial
cancer and prostate cancer |
| |
Cervical dysplasia |
| |
Early onset of annovulatory
cycles |
| |
Polycyctic ovaries |
| |
Uterine fibroids |
| |
Infertility due
to luteal phase failure leading to early
miscarriage |
| |
Sperm counts are
down over 50% in the last 50 years |
| |
Depression, anxiety
and panic attacks |
| |
Mood swings, agitation,
irritability |
| |
PMS |
| |
Chronic fatigue |
| |
Skin problems, teenage
acne |
| |
Memory loss and
foggy thinking, lacking power of concentration |
| |
Decreased libido |
| |
Early onset of menstruation,
irregular periods |
| |
Prememopausal bone
loss |
| |
Osteoporosis |
| |
Thyroid problems,
sluggish metabolism |
| |
Weight gain and
water retention |
| |
High blood pressure |
| |
Increase risk of
blood clots and therefore strokes |
| |
Migraine headaches |
| |
Gall bladder disease |
| |
Zinc/copper imbalance,
Magnesium deficiency |
| |
Hair loss |
Frequently
Asked Questions About Progesterone Cream
by John R. Lee, M.D.
and Virginia Hopkins
Q:
What is progesterone?
A: Progesterone
is a steroid hormone made by the corpus
luteum of the ovary at ovulation, and in
smaller amounts by the adrenal glands. Progesterone
is manufactured in the body from the steroid
hormone pregnenolone, and is a precursor
to most of the other steroid hormones, including
cortisol, androstenedione, the estrogens
and testosterone.
In a normally cycling female, the corpus
luteum produces 20 to 30 mg of progesterone
daily during the luteal phase of the
menstrual cycle.
Q: Why do
women need progesterone?
A: Progesterone
is needed in hormone replacement therapy
for menopausal women for many reasons, but
one of its most important roles is to balance
or oppose the effects of estrogen. Unopposed
estrogen creates a strong risk for breast
cancer and reproductive cancers.
Estrogen levels drop only 40-60% at menopause,
which is just enough to stop the menstrual
cycle. But progesterone levels may drop
to near zero in some women. Because progesterone
is the precursor to so many other steroid
hormones, its use can greatly enhance overall
hormone balance after menopause. Progesterone
also stimulates bone-building and thus helps
protect
against osteoporosis.
Q: Why not
just use the progestin Provera as prescribed
by
most doctors?
A: Progesterone
is preferable to the synthetic progestins
such as Provera, because it is natural to
the body and has no undesirable side effects
when used as directed.
If you have any doubts about how different
progesterone is from the progestins, remember
that the placenta produces 300-400 mg of
progesterone daily during the last few months
of pregnancy, so we know that such levels
are safe for the developing baby. But progestins,
even at fractions of this dose, can cause
birth defects. The progestins also cause
many other side effects, including partial
loss of vision, breast cancer in test dogs,
an increased risk of strokes, fluid retention,
migraine headaches, asthma, cardiac irregularities
and depression.
Q: What
is estrogen dominance?
A: Dr. Lee has
coined the term "estrogen dominance,"
to describe what happens when the normal
ratio or balance of estrogen to progesterone
is changed by excess estrogen or inadequate
progesterone. Estrogen is a potent and potentially
dangerous hormone when not balanced by adequate
progesterone.
Both women who have suffered from PMS and
women who have suffered from menopausal
symptoms, will recognize the hallmark symptoms
of estrogen dominance: weight gain, bloating,
mood swings, irritability, tender breasts,
headaches, fatigue, depression, hypoglycemia,
uterine fibroids, endometriosis, and fibrocystic
breasts. Estrogen dominance is known to
cause and/or contribute to cancer of the
breast, ovary, endometrium (uterus), and
prostate.
Q: Why would
a premenopausal woman need progesterone
cream?
A: In the ten
to fifteen years before menopause, many
women regularly have anovulatory cycles
in which they make enough estrogen to create
menstruation, but they don't make any progesterone,
thus setting the stage for estrogen dominance.
Using progesterone cream during anovulatory
months can help prevent the symptoms of
PMS.
We now know that PMS can occur despite normal
progesterone levels when stress is present.
Stress increases cortisol production; cortisol
blockades (or competes for) progesterone
receptors. Additional progesterone is required
to overcome this blockade, and stress management
is important.
Q: What
is progesterone made from?
A: The USP progesterone
used for hormone replacement comes from
plant fats and oils, usually a substance
called diosgenin which is extracted from
a very specific type of wild yam that grows
in Mexico, or from soybeans. In the laboratory
diosgenin is chemically synthesized into
real human progesterone. The other human
steroid hormones, including estrogen, testosterone,
progesterone and the cortisones are also
nearly always synthesized from diosgenin.
Some companies are trying to sell diosgenin,
which they label "wild yam extract"
as a medicine or supplement, claiming that
the body will then convert it into hormones
as needed. While we know this can be done
in the laboratory, there is no evidence
that this conversion takes place in the
human body.
Q: Where
should I put the progesterone cream?
A: Because progesterone
is very fat-soluble, it is easily absorbed
through the skin. From subcutaneous fat,
progesterone is absorbed into capillary
blood. Thus absorption is best at all the
skin sites where people blush: face, neck,
chest, breasts, inner arms and palms of
the hands.
Q: What
is the recommended dosage of progesterone?
A: For premenopausal
women the usual dose is 15-24 mg/day for
14 days before expected menses, stopping
the day or so before menses.
For postmenopausal women, the dose that
often works well is 15 mg/day for 25 days
of the calendar month.
Q: What
amount of progesterone do you recommend
in a cream?
A: Dr. Lee recommends
the creams that contain 450-500 mg of progesterone
per ounce, which is 1.6% by weight or 3%
by volume. This means that about 1ž4 teaspoon
daily would provide about 20 mg/day.
Q: How safe
is progesterone cream?
A: During the
third trimester of pregnancy, the placenta
produces about 300 mg of progesterone daily,
so we know that a one-time overdose of the
cream is virtually impossible. If you used
a whole jar at once it might make you sleepy.
However, Dr. Lee recommends that women avoid
using higher than the recommended dosage
to avoid hormone imbalances. More is not
better when it comes to hormone balance.
Q: Wouldn't
it be easier to just take a progesterone
pill?
A: Dr. Lee recommends
the transdermal cream rather than oral progesterone,
because some 80% to 90% of the oral dose
is lost through the liver. Thus, at least
200 to 400 mg daily is needed orally to
achieve a physiologic dose of 15 to 24 mg
daily. Such high doses create undesirable
metabolites and unnecessarily overload the
liver.
Q:Where
can I get more information on progesterone
and natural hormone balance?
A: For a detailed
explanation of women's hormone balance issues,
a hormone balance program, as well as detailed
descriptions of how to use natural progesterone,
the following books by John R. Lee, M.D.
are recommended:
What Your Doctor May Not Tell You About
Menopause: The Breakthrough Book on Natural
Progesterone, (Warner Books, 1996)
What Your Doctor May Not Tell You About
Pre menopause: Balance Your Hormones and
Life from Thirty to Fifty (Warner Books,
1999)
Dr. Lee's monthly
newsletter, the John
R. Lee, M.D. Medical Letter, is also
highly recommended for the latest news and
breakthroughs in hormone replacement therapy,
as well as practical, how-to information
on hormone balance and optimal health. For
more information visit www.johnleemd.com
online, call (800) 528-0559, or write to
P.O. Box 84900, Phoenix, AZ 85071.
HRT
EXPOSED
USA JAMA Reports - Study Gives HRT The Thumbs
Down.
July 2002
Major studies are weighing in giving HRT
the thumbs down. The consensus amongst the
more informed and enlightened of researchers
and clinicians is that the only real benefit
of HRT is for short term relief of hot flashes
( which is what it was originally approved
for). There is little doubt that the widespread
trend to use HRT for a range of therapeutic
benefits ie heart disease, prevention of
fractures, Alzheimer's Disease etc have
all but now faded in to the mists (myths)
of junk science. Millions of women have
unwittingly participated in this massive
experiment. Once again the rush for profits
without substantial, proven research has
jeopardized the health and, no doubt, the
lives of women around the world.
If hot flashes are the problem there are
many safe, effective ways to resolve them.
I still question the use of HRT which is
a made of two known carcinogens. Using such
options as natural progesterone cream, wild
yam cream, Maca, Vitamin E and C, Also,
liver support herbs such as milk thistle,
dandelion are also helpful. In addition
reduce or cut out the consumption of sugar,
caffeine, alcohol, deep fried foods, refined
carbohydrates and spicy food... major culprits
to hot flashes. Needless to say, reducing
stress levels, getting adequate rest and
hydrating the body with good quality water
are essential
The following study was released on July
2, 2002 in the Journal of the American Medical
Association.
Noncardiovascular Disease Outcomes During
6.8 Years of Hormone Therapy: Heart and
Estrogen/Progestin Replacement Study Follow-up
(HERS II)
http://jama.ama-assn.org/issues/v288n1/abs/joc20522.html
http://www.npr.org/ramfiles/atc/20020702.atc.07.ram
(Real Audio Player of National Public Radio
story)
HRT
'doubles breast cancer risk'
Taking certain types of hormone replacement
therapy (HRT) can double the risk of developing
breast cancer, says a study of more than
a million women.
The largest ever study into the link between
HRT and breast cancer was conducted by scientists
at Cancer Research UK's Epidemiology Unit
in Oxford.
The research suggests the single pill moderately
increases the risk of breast cancer, but
the combined pill doubles the risk.
It estimates HRT, taken by women to relieve
the unpleasant symptoms of menopause, may
have been responsible for an extra 20,000
cases of the disease in Britain in the last
decade.
The Committee on the Safety of Medicines
has reviewed the data and written to all
health professionals.
They stressed short-term HRT use is still
beneficial, but those taking it for more
than a year should heed the risks and discuss
them with their GP.
Barbara Sims took the combined HRT for six
years before being diagnosed with breast
cancer.
But she said she had no regrets because
it rescued her from an early menopause and
may have helped the detection of the cancer.
If women are put on HRT, they should
be screened for breast cancer every year
as a matter of course
Barbara Sims
Cancer sufferer
"Because my symptoms were so debilitating
I couldn't lead a normal life at all,"
she said.
About 1.5million women in the UK take HRT,
with half taking the combined version.
Hundreds of women have contacted the helpline
NHS Direct since hearing of the link with
breast cancer.
The researchers estimate there have been
20,000 cases of breast cancer over the last
decade in women aged 50 to 64 because of
HRT.
Steroid
risk
They say combined HRT is responsible for
15,000 of those cases.
The study is also the first to report that
HRT increases the risk of dying from breast
cancer, by 22%.
About 20 women in every 1,000 will usually
develop breast cancer.
But the study found for every 1,000 women
who use HRT for 10 years from the age of
50, there will be an additional 19 cases
of cancer in those using the combined oestrogen
and progestogen version and an extra five
in those using oestrogen-only HRT.
Using tibolone, a steroid treatment, also
increased a woman's cancer risk.
Women also have to bear in mind that oestrogen-only
HRT carries an increased risk of uterine
cancer.
Women's risk of developing breast cancer
decreases when she stops and is back to
normal levels after five years, claims the
research.
The data, published in The Lancet, covered
a million women who went for mammograms
between 1996 and 2001.
Careful consideration
Professor Valerie Beral, who led the research,
said: "Since our results show a substantially
greater increase in breast cancer with combined
HRT, women need to weigh the increased risk
of breast cancer caused by the addition
of progestogen against the lowered risk
of uterine cancer."
What
is HRT?
In late middle
age, a woman has reduced levels of some
sex hormones. This causes unpleasant symptoms
such as hot flushes, mood swings, loss of
libido. HRT aims to boost hormone levels
to reduce these symptoms.
Dr John Toy, Medical Director of Cancer
Research UK, said: "It would be sensible
for a woman to take HRT for only as long
as it is necessary to deal with her medical
problems as advised by her doctor.
"A woman wanting to take HRT for a
long time would be extremely wise first
to consider carefully the findings of this
large study and other relevant research."
Martin Ledwick, senior cancer information
nurse for Cancer BACUP, said: "We know
from the calls we get to our helpline, that
the impact of HRT on breast cancer risk
has been of concern to women for some time,
so it's good to have more evidence on this
issue.
"This will help women to make more
informed choices about their health, but
it will also cause anxiety - particularly
amongst women who have been on combined
HRT for some years."
Story
from BBC NEWS:
http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/3132495.stm
The
Greatest Experiment Even Performed
on Women
ONE YEAR
ago, 20 million American women woke up
and read the shocking news that combined
hormone therapy, instead of offering protection
from major diseases, actually increases
the risk for breast cancer, heart attack,
blood clots and stroke. Since then, we've
also learned that these drugs offer no
benefit for mood or sexual function and
double the risk for developing dementia.
Some women, such as Joan Levinson of Berkeley,
have greeted this news as a confirmation
of a lifelong skepticism of taking unnecessary
drugs. "When I reached menopause,"
Levinson says, "every doctor was
ready to pull out the prescription pad
for pills. I always said no. Reason? I
believe in the body and that the Original
Designer knows better than mere mortals
who have gone to medical school. So, barring
life-and-death medical situations, I usually
do not allow wonder drugs to enter my
sacred body."
But many women, for their own personal
reasons, followed their doctor's recommendation
and now, with varying degrees of difficulty,
are weaning themselves off hormone pills.
Not surprisingly, some women now feel
betrayed. The drug industry and many doctors
had promised that hormone therapy would
give postmenopausal women protection from
serious medical problems -- not to mention
the glow of eternal youthfulness.
How could the drug industry and medical
profession have been so wrong?
This is the question that Barbara Seaman
addresses in her forthcoming book, "The
Greatest Experiment Even Performed on
Women" (Hyperion, 2003), a splendid
history that exposes how menopause was
transformed into a medical problem and
who was responsible for identifying hormone
therapy as the medication for this "disease."
Seaman is a veteran health advocate and
journalist who, in 1971, authored the
famous "Doctor's Case Against the
Pill," an inquiry into the dangers
posed by birth control pills.
In a telephone interview from New York,
she explained why she wrote this book.
"I have a compulsion to disclose
the true history of these drugs and the
hidden knowledge that was kept from users.
Many of the risks, especially blood clots,
had long been known by research scientists.
Research on hormone therapy was mostly
smoke and mirrors and science by press
release."
Seaman blames this "great experiment"
on specific scientists, researchers and
drug companies who created "one of
the most elaborate promotional and advertising
campaigns in the history of the media."
The drug industry, in particular, not
only lobbied doctors, but also subsidized
research that would support their claims.
They also tried to discredit medical researchers,
doctors and health advocates who raised
serious doubts about tampering with women's
hormones.
What lessons should we learn from this
cautionary tale?
Cynthia Pearson, executive director of
the National Women's Health Network, says,
"We have to ensure that our regulatory
agencies have the resources they need
to protect us and we have to demand that
doctors prescribe based on evidence, not
on drug company marketing."
Seaman notes that "two-thirds of
the women who have gone off hormones are
doing just fine. Now we need research
that can identify which women really need
hormone therapy, instead of giving it
to everyone who turns 50."
In addition, she also warns that "everyone's
desperately looking for alternatives."
So we should expect a growth industry
in all kinds of alternatives -- including
"the estrogen patch," herbal
supplements, and topical and inserted
use of hormonal products.
Trust only a herbal product that has been
used for centuries and has known benefits,
a product
that is a food, or a supplement
or topical application that has the identical
molecule to that which your body produces
naturally.
The range of acceptable alternatives are:-
a)Herbal Products that are well known for their balancing effects.
b)Natural Vitamins and Minerals and Organic food supplements
c)Natural Progesterone topical creams provided they are in a natural based
cream, and are NOT Wild Yam.
<<
Back >>
Hormone replacement
therapy study halted, Increased risk of
breast cancer a factor, government says
July 9, 2002 Posted: 3:07 PM EDT (1907
GMT)
WASHINGTON (CNN) -- In a move that may
affect millions of women, U.S. government
scientists Tuesday stopped a major study
of hormone replacement therapy on the
risks and benefits of combined estrogen
and progestin in healthy menopausal women,
citing an increased risk of invasive breast
cancer.
Researchers from
the National Heart, Lung and Blood Institute
of the National Institutes of Health also
found increases in coronary heart disease,
stroke and pulmonary embolism.
The study further
clouds an issue that already was confusing
for many women. Contradicting research
about the risks and benefits of hormone
replacement therapy has been periodically
released for years. The only consensus
among experts is that the decision is
an individual one since every woman's
lifestyle issues and risk profile is different.
"Women
with a uterus who are currently taking
estrogen plus progestin should have a
serious talk with their doctor to see
if they should continue it," said
Jacques Rossouw in a statement. Rossouw
is acting director of the Women's Health
Initiative, which sponsored the study.
"If they
are taking this hormone combination for
short-term relief of symptoms, it may
be reasonable to continue since the benefits
are likely to outweigh the risks,"
Rossouw continued. "Longer term use
or use for disease prevention must be
re-evaluated."
A statement from
the institute noted the benefits of estrogen
combined with progestin, "including
fewer cases of hip fractures and colon
cancer, but on balance the harm was greater
than the benefit."
About 6 million
women in the United States are taking
estrogen and progestin for various reasons,
including relief of menopausal symptoms
and long-term use for the prevention of
heart disease and brittle bones.
The estrogen and
progestin trial study involved 16,608
women ages 50 to 79 with an intact uterus.
A major objective
of the trial study was to explore the
effect of estrogen and progestin on the
prevention of heart disease and hip fractures
and any associated change in risk for
breast and colon cancer.
"We have
long sought the answer to the question:
Does postmenopausal hormone therapy prevent
heart disease and, if it does, what are
the risks? The bottom-line answer from
[the Women's Health Initiative] is that
this combined form of hormone therapy
is unlikely to benefit the heart,"
said Dr. Claude Lenfant, director of the
heart, lung and blood institute, in a
statement.
"The
cardiovascular and cancer risks of estrogen
plus progestin outweigh any benefits --
and a 26 percent increase in breast cancer
risk is too high a price to pay, even
if there were a heart benefit. Similarly,
the risks outweigh the benefits of fewer
hip fractures.
"Men
pausal women who might have been candidates
for estrogen plus progestin should now
focus on well-proven treatments to reduce
the risk of cardiovascular disease, including
measures to prevent and control high blood
pressure, high blood cholesterol and obesity,"
Lenfant continued.
In a statement,
Garnet Anderson, a biostatistician who
led the analysis at the Fred Hutchinson
Cancer Research Center in Seattle, Washington,
said, "The trial was stopped at the
first clear indication of increased risk."
Anderson also said
that, at that point, there was no indication
of increased risk for breast cancer in
the estrogen-only group.
RECOMMENDED
READING
Progesterone
| |
Bond, Shirley,
M.D., Rushton, Anna and Dr. Shirley
A. Bond, Natural Progesterone(1999)
(Thorsons) |
| |
Lee, John R., M.D.,
What Your Doctor May Not Tell You About
Menopause (1996) (Warner, New York) |
| |
Lee, John R., M.D.,
What Your Doctor May Not Tell You About
Premenopause (1999) (Warner, New York) |
| |
Lee, John R., M.D.,
Natural Progesterone: The Multiple Roles
of a Remarkable Hormone (1995) ( BLL
Publishing, Sebastopol, CA, U.S.A.) |
| |
Lee, John R., M.D.,
What Your Doctor May Not Tell You About
Cancer
(2002) (Warner, New York) |
| |
Susan E Brown Ph.D.,
Better Bones Better Body (Keats
Publishing Inc) |
| |
Martin, Raquel with
Judi Gerstung, D.C., The Estrogen Alternative
(1997) (Healing Arts Press, Rochester,
Vermont, USA) |
| |
Neil, Kate and
Patrick Holford, Balancing Hormones
Naturally (1998) (Judy Piatkus Ltd,
London) |
| |
Dalton, Katharina,
M.D., Premenstrual Syndrome (1964) (Heinemann
Medical Books, London) |
| |
Dalton, Katharina,
M.D., The Menstrual Cycle (1969) (Penguin
Books, London ) |
| |
Dalton, Katharina,
M.D., Depression After Childbirth (1989)
(Oxford University Press, Oxford) |
| |
Dalton, Katharina,
M.D., Premenstrual Syndrome and Progesterone
Therapy (1984) (Heinemann Medical Books,
London and Year Book Inc., Chicago).
Revised 2nd edition |
| |
Dalton, Katharina,
M.D., PMS Illustrated (1990) (Peter
Andrew Publishing Co.) |
| |
Dalton, Katharina,
M.D., PMS - The Essential Guide to Treatment
Options (Thorsons, London) |
| |
Dalton, Katharina,
M.D., Premenstrual Syndrome goes to
Court (1990) (Peter Andrew Pub. Co.,
UK) |
| |
Dalton, Katharina,
M.D., Once a Month (1991 ) (Fontana) |
| |
Kenton, Leslie,
Passage to Power - Natural Menopause
Revolution (1995) (Ebury Press, London)
|
| |
Owen, N, Nicola
- The case that made legal history (1992)
(Bantam Press) |
General
| |
Cadbury, Deborah,
The Feminisation of Nature (1997) (Hamish
Hamilton, London, UK) |
| |
Chopra, Deepak,
M.D., Quantum Healing (1989) (Bantam
Books, New York) |
| |
Chopra, Deepak,
M.D., Ageless Body, Timeless Mind (Bantam
Books, New York) |
| |
Colborn, Theo, Our
Stolen Future (1996) (Abacus, London,
UK.) |
| |
Gellatley, Juliet
with Tony Wardle, The Silent Ark (1996)
(Thorsons, London, UK) |
| |
McTaggart, Lynne,
What Doctors Don't Tell You (1996) (Thorsons,
London, UK) |
| |
Northrup, Christiane,
M.D., Women's Bodies, Women's Wisdom
(1995) (Judy Piatkus Ltd, London) |
| |
West, Stanley,
M.D., The Hysterectomy Hoax (1994) (Doubleday,
New York) |
Menopause
| |
Coney, Sandra,
The Menopause Industry (1995) (The Women's
Press, London) |
| |
Kenton, Leslie,
Passage to Power - Natural Menopause
Revolution (1995) (Ebury Press, London) |
| |
Lee, John R., M.D.,
What Your Doctor May Not Tell You About
Menopause (1996) (Warner , New York) |
|
|